The new HER2-low category is exposing the limitations of IHC testing, challenging pathologists, and has oncologists ...
The new HER2-low category is exposing the limitations of IHC testing, challenging pathologists, and has oncologists ...
Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.
A significant advance in breast cancer research has uncovered a key mechanism driving cancer invasion and drug resistance. A ...
A new method of analyzing mammograms identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did. The new method, powered by ...
The study highlights how EV-DNA packaging influences immune responses and its promise as a biomarker for assessing colorectal ...
A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells survive in bone marrow despite targeted therapies.
This roundup includes a selection of abstracts on early and metastatic breast cancer presented at the 2024 San Antonio Breast ...
Brain cancer originates in the brain and consists of brain cancer cells. But brain metastases from lung cancer occur when cancer cells break off from the tumor in the lungs and enter the ...
With more than 150 treatments being studied in clinical trials, what is on the horizon for antibody-drug conjugates in breast ...
Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. If you’re covering the American Society of Hematology (ASH) Annual Meeting, Dec. 7-10 in San ...